4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-19-061091
Chief Executive Officer acquired 8,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kulkarni Samarth Chief Executive Officer | 2019-12-16 | Option exercise | +8,000 | $1.81 | $14,480 | 172,320 | D |
| Derivatives | |||||||
| Kulkarni Samarth Chief Executive Officer | 2019-12-16 | Option exercise · Stock Option (Right to Buy) | −8,000 | 195,058 | D | ||
Loading xslF345X03/doc4.xml…